We are live on ! Find out more
ELOS

Syneron Medical Ltd
ELOS

Delisted

ELOS was delisted on the 14th of July, 2017.

61 hedge funds and large institutions have $181M invested in Syneron Medical Ltd in 2016 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 24 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

7% more funds holding

Funds holding: 5761 (+4)

8% less capital invested

Capital invested by funds: $196M → $181M (-$15.7M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

54% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 24

Holders
61
Holders Change
+4
Holders Change %
+7.02%
% of All Funds
1.63%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
9
Increased
11
Reduced
24
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SM
1
Senvest Management
New York
$28.3M -$71.6K -10,000 -0.3%
NTC
2
North Tide Capital
Massachusetts
$25.6M
JP Morgan Chase
3
JP Morgan Chase
New York
$19.5M -$1.25M -173,968 -6%
BIP
4
Brandes Investment Partners
California
$18.3M +$5.47M +763,777 +44%
DGHMC
5
Dalton, Greiner, Hartman, Maher & Co
New York
$13.1M -$114K -15,926 -0.9%
CCM
6
Camber Capital Management
Massachusetts
$11M
SAM
7
Senzar Asset Management
New York
$9.27M -$991K -138,300 -10%
IAM
8
Ion Asset Management
Israel
$8.23M -$552K -77,017 -6%
Renaissance Technologies
9
Renaissance Technologies
New York
$6.79M +$202K +28,200 +3%
BC
10
Broadfin Capital
New York
$6.36M -$1.33M -185,208 -18%
RA
11
Royce & Associates
New York
$5.21M +$358K +50,000 +8%
GIM
12
Granahan Investment Management
Massachusetts
$4.79M -$1.28M -179,059 -21%
Deutsche Bank
13
Deutsche Bank
Germany
$3.78M -$120K -16,700 -3%
Ameriprise
14
Ameriprise
Minnesota
$3.5M -$376K -52,550 -10%
PCM
15
Perritt Capital Management
Illinois
$2.75M -$168K -23,500 -6%
Millennium Management
16
Millennium Management
New York
$2.18M -$2.79M -388,829 -57%
LAM
17
Lapides Asset Management
Connecticut
$2.08M +$331K +46,200 +19%
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$1.28M -$104K -14,523 -8%
USAA
19
United Services Automobile Association
Texas
$1.15M -$201K -28,086 -15%
TA
20
Teton Advisors
New York
$740K
PIM
21
Profit Investment Management
Maryland
$649K +$351K +48,985 +123%
DCM
22
DAFNA Capital Management
California
$628K
Two Sigma Advisers
23
Two Sigma Advisers
New York
$613K -$117K -16,300 -16%
California Public Employees Retirement System
24
California Public Employees Retirement System
California
$585K +$70.2K +9,800 +14%
GCP
25
GSA Capital Partners
United Kingdom
$524K -$210K -29,297 -29%

ELOS Hedge Fund Activity: Q1 2016 in Review

61 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q1 2016, worth a combined $181M — down 8% from $196M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new ELOS positions and 5 closed out — a net gain of 4 holders — while 11 added to existing stakes and 24 trimmed.

The largest buyer was Brandes Investment Partners, adding an estimated $5.47M. The largest seller was Millennium Management, cutting an estimated $2.79M.

  • 61 institutional investors held Syneron Medical Ltd (ELOS) as of Q1 2016, up from 57 in Q4 2015.
  • Funds reported $181M of Syneron Medical Ltd stock for Q1 2016, down 8% quarter-over-quarter.
  • 9 funds opened new Syneron Medical Ltd positions in Q1 2016 and 5 closed out, a net change of +4 holders.
  • The largest Syneron Medical Ltd buyer in Q1 2016 was Brandes Investment Partners, an estimated $5.47M added.
  • The largest Syneron Medical Ltd seller in Q1 2016 was Millennium Management, an estimated $2.79M sold.

Based on aggregated 13F filings for Q1 2016.